Carcinoma, Hepatocellular: all 3,249 studies
Page 31 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Study in Asia of the Combination of TACE With Sorafenib in HCC PatientsStatus unknownNCT00990860Phase 2
- Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic TherapyCompletedNCT00988741Phase 2
- Study of Pegylated Human Recombinant Arginase for Liver CancerCompletedNCT00988195Phase 1
- A Study to Assess PV-10 Chemoablation of Cancer of the LiverStatus unknownNCT00986661Phase 1
- Trial of TG4023 Combined With Flucytosine in Liver TumorsCompletedNCT00978107Phase 1
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)CompletedNCT00976170Phase 1
- Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)TerminatedNCT00971126Phase 1/2
- Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular CarcinomaTerminatedNCT00966251Phase 1/2
- Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)CompletedNCT00963612Not applicable
- TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)Status unknownNCT00960518Phase 2
- A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)Status unknownNCT00960167Phase 1
- Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)CompletedNCT00956436Phase 1
- 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT00943449Phase 2
- Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACECompletedNCT00936689Phase 4
- Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion ChemotherapyCompletedNCT00933816Phase 1/2
- Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)CompletedNCT00923897Phase 2
- Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular CarcinomaStatus unknownNCT00921531Phase 3
- Safety Study of Foretinib (GSK1363089) in Adults With Liver CancerCompletedNCT00920192Phase 1
- Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC)CompletedNCT00919009Phase 2
- Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)CompletedNCT00914355Phase 2
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore AreaCompletedNCT00913757
- Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular CarcinomaCompletedNCT00912847
- Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular CarcinomaCompletedNCT00911196
- Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaCompletedNCT00910572Phase 2
- Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on CancerSuspendedNCT00909558Phase 1
- Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCCCompletedNCT00908752Phase 3
- TheraSphere® for Treatment of Unresectable Hepatocellular CarcinomaApproved for marketingNCT00906984
- A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor MarkStatus unknownNCT00902902
- Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)CompletedNCT00892658Phase 1
- An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037CompletedNCT00884520Early Phase 1
- Estimation of Functional Liver Reserve Using CholinesterasesCompletedNCT00883454
- XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00882869Phase 1/2
- A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®CompletedNCT00877136
- A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerCompletedNCT00872014Phase 2
- SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00867750Phase 2
- Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With HepatomaCompletedNCT00861783Phase 1
- First Line Hepato Cellular Carcinoma (HCC)CompletedNCT00858871Phase 3
- Analysis of Expression of Specific Markers in Hepatocellular CarcinomaCompletedNCT00858000
- A Trial of Complete Versus Selective HepaticVascular Clamping in HepatectomyCompletedNCT00851968Not applicable
- Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma PatientsCompletedNCT00849264Phase 2
- Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on CirrhosisStatus unknownNCT00848952Not applicable
- Radiation Dose Escalation Study for Advanced Liver CancerCompletedNCT00848094Phase 1
- Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular CarcinomaCompletedNCT00846131Phase 1
- Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00844688Phase 2
- TK-based Suicide Gene Therapy for Hepatocellular CarcinomaCompletedNCT00844623Phase 1
- Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular CarcinomaCompletedNCT00844454Not applicable
- Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver TransplantCompletedNCT00844168Phase 1
- Trial of Transcatheter Arterial Chemoembolization for Hepatocellular CarcinomaStatus unknownNCT00843934Phase 2/3
- Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular CarcinomaStatus unknownNCT00842647
- The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular CarcinomaWithdrawnNCT00838968Not applicable
- Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular CarcinomaStatus unknownNCT00834860Phase 4
- Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCCCompletedNCT00834158Not applicable
- Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial ChemoembolizationCompletedNCT00834028
- Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular CarcinomaCompletedNCT00829465Phase 4
- Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided ApproachCompletedNCT00829335
- Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00828594Phase 1
- Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With HepatocarcinomaCompletedNCT00827723
- The Role of Low Molecular Weight Heparins in Hepatocellular CarcinomaCompletedNCT00827554Phase 2/3
- Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma TreatmentCompletedNCT00827047Not applicable
- Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing PerfusionCompletedNCT00826384Phase 1/2
- Long-term Follow-up of HALT-C Sustained Virological RespondersCompletedNCT00825877
- Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma ResectionCompletedNCT00825669Not applicable
- A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular CarcinomaCompletedNCT00825474Not applicable
- Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)TerminatedNCT00823290Phase 1
- Sonazoid Enhanced Liver Cancer Trial for Early DetectionStatus unknownNCT00822991Not applicable
- Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver CancerCompletedNCT00822562Not applicable
- Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in HepatectomyCompletedNCT00820339Phase 2/3
- Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular CarcinomaCompletedNCT00820157Not applicable
- A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver ResectionCompletedNCT00820053Phase 2
- A Trial of Licartin for Preventing Tumor Recurrence After Liver ResectionCompletedNCT00819650Phase 2
- Intraoperative Chemotherapy Against Hepatocellular Carcinoma RecurrenceCompletedNCT00817895Not applicable
- Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood VesselsCompletedNCT00814242Phase 2/3
- Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With SorafenibCompletedNCT00812175
- Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT00808145Phase 2
- Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00807300Phase 2
- Songyou Granule and Transarterial Chemoembolization for Hepatocellular CarcinomaStatus unknownNCT00805896Phase 2
- Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)CompletedNCT00802555Phase 1
- Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger CompressionStatus unknownNCT00797251
- INSIGHT - Post Marketing SurveillanceCompletedNCT00792350
- Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver CarcinomaTerminatedNCT00791544Phase 1/2
- Phase I/II Study of TSU-68 for Advanced Hepatocellular CarcinomaCompletedNCT00784290Phase 1/2
- Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001CompletedNCT00775073Phase 2
- Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral ReplicationCompletedNCT00769730
- Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular CarcinomaCompletedNCT00769535Not applicable
- Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver CancerCompletedNCT00769106Phase 3
- Sorafenib and Transarterial Chemoembolization for Hepatocellular CarcinomaCompletedNCT00768937Phase 1/2
- Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular CarcinomaStatus unknownNCT00768157Phase 4
- Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular CarcinomaTerminatedNCT00767936
- Permission to Collect Blood Over Time for ResearchTerminatedNCT00767234
- Tumor Growth Factors in Hepatocellular CarcinomaCompletedNCT00764140
- Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic DissectorTerminatedNCT00763776Not applicable
- A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT00756782Phase 2
- Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular CarcinomaStatus unknownNCT00752063Phase 2
- SBRT + TACE for Primary Hepatocellular CarcinomaWithdrawnNCT00746655Not applicable
- A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)CompletedNCT00746317Phase 1
- Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an OptionCompletedNCT00740753Not applicable
- Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACEStatus unknownNCT00730860Not applicable
- Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00728078Phase 2/3
- Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative HepatectomyCompletedNCT00725335Not applicable
- The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular CarcinomaStatus unknownNCT00720668